Back to overview
October 12, 2021
1 minute

Nivolumab + Cabozantinib for the treatment of advanced Renal-Cell Carcinoma in 1L

IPSEN and Bristol Myers Squibb webinar.
Speakers: Petri Bono, Viktor Grünwald, MD and Thomas Powles MBBS, MRCP, MD.
Date: 12 October 2021